Megabus to Bring Pets to Philadelphia Hospital in Support of Breast Cancer Awareness Month
To date, megabus.com has donated $50,000 to BCRF. Later this month, in partnership with Pet Partners, megabus.com will transport therapy animals to visit with patients and hospital staff at Penn Presbyterian Medical Center in Philadelphia.
"Many people, including our employees and passengers, are affected by breast cancer,” said Sean Hughes, director of corporate affairs for megabus.com. “In addition to spreading awareness and encouragement this month, we hope that our annual donations to BCRF will one day lead to a cure for breast cancer.”
The unique BCRF pink megabus will again hit the road throughout the entire month of October, making stops in various cities across the country.
Mid-month, a unique stop in Philadelphia at Penn Presbyterian Medical Center will have special passengers on board: therapy dogs. The animals will visit with patients currently undergoing treatment during a special animal-assisted therapy session, proven to aid both physically and emotionally. Before departing, megabus.com will also make a donation to the hospital.
“Cancer treatments are intimidating and can be emotionally draining,” said Elisabeth Van Every, Communications & Outreach Coordinator with Pet Partners. “We hope that when our therapy animal teams step off the pink megabus, they bring smiles and help lift spirits for those undergoing treatment, not only during the time spent with the therapy dogs, but in the days and months ahead.”
Since its launch on April 10, 2006, Megabus.com has served more than 60 million customers. Megabus.com maintains the highest (Satisfactory) safety compliance rating with the Federal Motor Carrier Safety Administration and is approved by Transportation Safety Exchange (TSX), an independent safety rating organization. Megabus.com currently operates service to/from more than 120 major cities in North America and 23 hubs.
ABOUT BREAST CANCER RESEARCH FOUNDATION
The Breast Cancer Research Foundation (BCRF) is dedicated to being the end of breast cancer by advancing the world's most promising research. Founded by Evelyn H. Lauder in 1993, BCRF-funded investigators have been deeply involved in every major breakthrough in breast cancer prevention, diagnosis, treatment and survivorship. This year, BCRF has awarded $63 million in grants to support the work of nearly 300 scientists at leading medical and academic institutions across 14 countries, making BCRF the largest private funder of breast cancer research worldwide. BCRF is also the highest rated breast cancer organization in the U.S. Visit www.bcrf.org to learn more.